NIH-funded research R01 grant

Understanding the genetics and biology behind suicide outcomes

Official title: Establishing the Suicide Working Group of the Psychiatric Genomics Consortium to elucidate the genetics and biology of suicide outcomes

Funded at Icahn School of Medicine at Mount Sinai · NIH-10995296 · Data updated 2026-11-12

This study is looking at how our genes and biology might influence thoughts of suicide and attempts, and it's for anyone interested in understanding the deeper reasons behind these feelings, especially those affected by mental health issues.

More Suicide research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startDecember 6, 2023
Project endOctober 31, 2028
Funding year2025
Award (this year)$686,792
NIH project number5R01MH132733-02
Project IDNIH-10995296 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a history of suicidal ideation, suicide attempts, or those who have experienced the loss of a loved one to suicide.

Less likely to help

Patients who do not have any history of suicidal thoughts or behaviors may not benefit from this research.

What this research studies

This research aims to explore the genetic and biological factors that contribute to various suicide outcomes, including suicidal ideation, suicide attempts, and suicide deaths. By establishing the Suicide Working Group of the Psychiatric Genomics Consortium, the project will conduct large-scale genetic studies involving a diverse population to identify genetic markers associated with these outcomes. The research will utilize data from clinical, population, and medical examiner resources to better understand the heritability and biological underpinnings of suicide-related behaviors. This comprehensive approach seeks to illuminate the connections between suicide outcomes and psychiatric disorders.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention strategies and targeted treatments for individuals at risk of suicide.

How similar studies have gone: Previous research in psychiatric genomics has shown promise in identifying genetic factors related to mental health disorders, suggesting potential for success in this novel approach to studying suicide outcomes.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Mullins, Niamh — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Mullins, Niamh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.